This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Weiqiang Zhan: Innovator in Pyrazole Compounds
Introduction
Weiqiang Zhan is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his work on pyrazole compounds. His innovative approach has led to advancements in the treatment of conditions related to methionine aminopeptidase 2 (MetAP2) and dipeptidyl peptidase-4 (DPP-4).
Latest Patents
Weiqiang Zhan holds 1 patent for his invention related to pyrazole compounds. This invention focuses on compounds that act as inhibitors of MetAP2 and DPP-4. These compounds are particularly valuable in the treatment of obesity and type 2 diabetes mellitus. The patent outlines the dual inhibitory activity of these compounds, which can be beneficial in managing conditions mediated by both MetAP2 and DPP-4.
Career Highlights
Zhan is currently associated with Eli Lilly and Company, where he continues to contribute to pharmaceutical research and development. His work has been instrumental in creating novel compounds that address significant health issues.
Collaborations
Throughout his career, Weiqiang Zhan has collaborated with notable colleagues, including Koc Kan Ho and Jingye Zhou. These collaborations have further enhanced the research and development of innovative pharmaceutical solutions.
Conclusion
Weiqiang Zhan's contributions to the field of pyrazole compounds exemplify the impact of innovative research in pharmaceuticals. His work not only advances scientific knowledge but also holds promise for improving patient care in various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile